| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Vitamin d metabolism 0.9532563985913004 3.501458852965277 0.0004627184169565 0.2364886349133189 0.0096459205807579 3 P38435 1 |
| Prostaglandin and leukotriene metabolism in senescence 0.8797580932052649 3.357305868033694 0.0007870599190442 0.3681078835104808 0.0138405559508779 2 P63096 1 |
| Eicosanoid synthesis 0.8609035930273927 3.2699670800313023 0.0010756000104503 0.4660282205797115 0.0145831350254085 2 P09960 1 |
| Urea cycle and related diseases 0.8388473852721481 3.166549147842132 0.0015425927640462 0.5934408893073694 0.0195506865530206 2 Q9Y619 1 |
| Pkcgamma calcium signaling pathway in ataxia 0.8274635361081508 3.1126345771423996 0.0018542545242108 0.6610944693337077 0.0225214664086441 2 Q15118 1 |
| Electron transport chain oxphos system in mitochondria 0.5021501315373926 3.0022711836675486 0.0026797334236028 0.7907826439195562 0.0275103183417323 57 Q9UDW1,O75880,P14406,O14949,O75438,O75964,O75306,O43676,P00403,P13073,P21912,Q7KZN9,P03886,P00846,P24539 15 |
| Proteoglycan biosynthesis 0.8800879670390995 2.9997560094660516 0.0027019595130548 0.7934833742843885 0.0275103183417323 4 Q8TB61 1 |
| Sars coronavirus and innate immunity 0.776947705442909 2.868829678845694 0.0041199358809653 0.9099044165875758 0.0350255740793235 2 Q7Z434 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8136472951193588 2.8687199945732895 0.004121364745514 0.9099797477666876 0.0350255740793235 3 P09601 1 |
| Sphingolipid metabolism in senescence 0.7875435262400932 2.657424181693147 0.0078740299594406 0.990035514961324 0.0527650513374011 12 Q13510,P04062,O15121,Q96G23,P16278,Q06136 6 |
| Metabolism of spingolipids in er and golgi apparatus 0.8232203508512428 2.6109709538599177 0.0090285561773004 0.9949458915936578 0.0573301741181968 5 Q06136,Q16739,O95470 3 |
| Purinergic signaling 0.7570597974230935 2.597180164698562 0.0093992609170983 0.9959363940023296 0.0582954161134927 3 P63096 1 |
| Sphingolipid metabolism integrated pathway 0.7975418692267132 2.5498246698487597 0.0107777105920794 0.9981955706957713 0.0643676038062065 10 Q13510,Q16739,O15121,Q96G23,O95470,Q06136 6 |
| Type i interferon induction and signaling during sarscov2 infection 0.747106446157501 2.548460940341448 0.0108199402624498 0.9982399262692264 0.0643676038062065 3 Q7Z434 1 |
| Sphingolipid metabolism overview 0.7985290259101101 2.502413276407125 0.0123349841605628 0.9992798248819528 0.0712063151511748 9 Q13510,O15121,Q16739,Q96G23,O95470,Q06136 6 |
| Nocgmppkg mediated neuroprotection 0.7701095483048338 2.492154305184283 0.0126970862863224 0.9994184405706664 0.0718199249575806 4 P30536 1 |
| Degradation pathway of sphingolipids including diseases 0.8244531950039958 2.488958620208984 0.0128117876425186 0.999456527907938 0.0718199249575806 6 P06280,P06865,O43681,P16278 4 |
| Sphingolipid pathway 0.7802109047015925 2.4650626529321795 0.0136989295646678 0.9996782332951304 0.0753441126056734 10 Q13510,P04062,Q96G23,O95470,Q06136 5 |
| Kennedy pathway from sphingolipids 0.7593269890032696 2.440646541735156 0.0146609963749442 0.9998178420732052 0.0777032807872043 4 Q9UG56,O95470 2 |
| Interactions between loxl4 and oxidative stress pathway 0.6894343649946706 2.4279608638622228 0.015183981659308 0.9998663325745542 0.0790380473872908 2 Q9BQ95 1 |
| Glycosaminoglycan degradation 0.7991086535002141 2.37358344683572 0.0176164119091788 0.9999683859313874 0.0855864011920938 6 P06865,P54802,P16278 3 |
| Ferroptosis 0.5903449909287716 2.3528927592778066 0.0186280055856185 0.9999826610040444 0.088293717531834 21 Q9Y277,P45880,Q6P1A2,P09601,Q9NZ45,Q96QD8 6 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.7056939501779549 2.34261686251777 0.0191490360349495 0.9999872777903844 0.0887378713950515 3 Q15118,Q15382 2 |
| Steroid biosynthesis 0.6723585912486733 2.339094402516461 0.0193305483141879 0.9999885790239564 0.0887378713950515 2 Q99829 1 |
| Pilocytic astrocytoma 0.6631092138029249 2.2905649202601195 0.0219885897799403 0.9999976530366528 0.0982170562692614 2 Q06124 1 |
| Mitochondrial complex iv assembly 0.694890641108258 2.272790699219882 0.0230387957948805 0.9999987454835684 0.0990295546850136 13 P14406,Q9Y2R0,P00403,Q15526,P13073,O43819,Q7KZN9 7 |
| Inclusion body myositis 0.6904747278277336 2.2656879003063612 0.0234704988884191 0.9999990304515828 0.0991543539996257 3 Q92542 1 |
| Statin inhibition of cholesterol production 0.700716652223559 2.1550888513957744 0.0311548819663658 0.999999990310774 0.1202867297112005 4 Q8WTV0 1 |
| Oxidation by cytochrome p450 0.722797391036212 2.1388473235621883 0.0324480353811904 0.9999999955524956 0.122046481466026 5 O43169,Q6UW02,P16435 3 |
| Glycerolipids and glycerophospholipids 0.6921022973644618 2.112325995835668 0.0346584976248662 0.9999999988277772 0.1295250263801092 4 Q9UG56 1 |
| Nonalcoholic fatty liver disease 0.447431918216805 2.0523229421040363 0.0401382878237805 0.999999999957572 0.1398001711237563 49 Q9UDW1,P14406,Q86Y39,O14949,O75438,Q9P0J0,O75306,O43676,P00403,P13073,P21912 11 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.6841546559963874 1.936764250351152 0.0527741677852477 0.9999999999999812 0.1601897488929081 9 O95433 1 |
| Ciliopathies 0.6175914833126317 1.9364628772466683 0.0528110349627617 0.9999999999999816 0.1601897488929081 14 Q10713,O43924,Q13432 3 |
| Mitochondrial immune response to sarscov2 0.6678939061964485 1.8952983925159623 0.0580528810251079 0.9999999999999992 0.1654362189612567 10 Q86UT6,Q9BQ95,Q7Z434,Q99623,Q9Y375,Q9Y6M9,Q9H845 7 |
| Mitochondrial complex iii assembly 0.6677215959870321 1.8943975953355543 0.0581722553808878 0.9999999999999992 0.1654362189612567 10 Q9UDW1,O14949,Q6DKK2,P14927,Q9NVA1,Q9BRT2,P08574 7 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5140618063509466 1.8091473925120516 0.0704281080004607 1.0 0.1866344862012209 21 Q15800,O00767,Q16850,P48449,P14324,Q14534,Q14739,Q15392 8 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.6541610343324727 1.8013724518655432 0.0716441951717374 1.0 0.188626035854682 5 Q7Z434 1 |
| Nad metabolism 0.6007063435159854 1.7981687659843582 0.0721502675739178 1.0 0.188626035854682 3 P43490 1 |
| Nad biosynthetic pathways 0.6007063435159854 1.7981687659843582 0.0721502675739178 1.0 0.188626035854682 3 P43490 1 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.6504778242933098 1.7829430770907269 0.0745955698904572 1.0 0.192430164805914 5 Q7Z434 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6178778445472919 1.7517955161381786 0.0798089755059119 1.0 0.2022984031302028 12 P42167,O60725,P55209 3 |
| S1p receptor signal transduction 0.6538484316851014 1.6825526150896393 0.0924617312789317 1.0 0.2236729847950921 6 P63096,Q13510 2 |
| Familial partial lipodystrophy fpld 0.6459092996172039 1.643429266168239 0.1002941490648305 1.0 0.2396372496098206 6 O60725 1 |
| Nephrotic syndrome 0.5775958619303747 1.5244773603406472 0.1273895081205145 1.0 0.2823881491796957 12 Q96D53,O75844,Q14108 3 |
| Alzheimers disease and mirna effects 0.3485649621723681 1.511307064589864 0.130710234869442 1.0 0.2864814546198672 79 Q99436,P21796,Q9Y277,Q9BVA1,P45880,Q9NQC3,Q92542,P05067,P28070,P12235,P04350,O95197,P12236,P49721,P28072,P28074,Q8NE86,O14654,Q96IX5,P60900,P07437 21 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.5133404482390742 1.4684177640733518 0.1419907791873678 1.0 0.3043405303905714 2 Q8TD30 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.5813410974662105 1.431911357210608 0.1521691915057912 1.0 0.317973615225363 5 Q14739,Q15392 2 |
| Alzheimers disease 0.3447249539397506 1.4128938145759915 0.1576869480689982 1.0 0.3259981940575388 77 Q99436,P21796,Q9Y277,Q9BVA1,P45880,Q9NQC3,Q92542,P05067,P28070,P12235,P04350,O95197,P12236,P49721,P28072,P28074,Q8NE86,O14654,P60900,P07437 20 |
| Mitochondrial complex i assembly model oxphos system 0.4261130738148499 1.4040020225610583 0.1603182472886701 1.0 0.3283995594175656 30 O75438,Q96CU9,Q9P0J0,O43676,O75306,Q9NW81,Q8IUX1,O96000,P03886,Q9Y6M9 10 |
| Cellular proteostasis 0.5416139277989798 1.3362224043256246 0.1814765901904489 1.0 0.3598668438130331 4 Q9UHV9,P61758 2 |
| Oxidative phosphorylation 0.4119449586793794 1.3213308346525352 0.1863910769683106 1.0 0.3658787807155726 34 Q86Y39,O75438,O75964,O75306,Q9Y6M9,P03886,P00846,P24539 8 |
| Mitochondrial long chain fatty acid betaoxidation 0.5267360716906663 1.3061323368551143 0.1915075579162328 1.0 0.3721630208838792 13 P11310,P40939,O43772,P23786 4 |
| Joubert syndrome 0.4939157461368988 1.270763184820739 0.2038129095861638 1.0 0.3870885738500305 15 Q10713,O43924,Q13432 3 |
| Adipogenesis 0.5076551598066488 1.2706992455380963 0.2038356641028462 1.0 0.3870885738500305 14 Q92879,O00767,P43490,O14654,P42224,Q9NZ45,O75844 7 |
| Heme biosynthesis 0.5368563956199488 1.20246414502179 0.2291837497345505 1.0 0.4210880167352174 5 P22830,P36551,P50336 3 |
| Glycosylation and related congenital defects 0.5525367203527041 1.1966632617880266 0.2314378319970607 1.0 0.4227997334701415 7 Q9BT22,Q9BV10,Q9H0U3 3 |
| Ketogenesis and ketolysis 0.5506290709184697 1.166820643175824 0.2432828086310912 1.0 0.4324203580241651 6 O43772,P23786 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.5069435106454329 1.152264432288538 0.2492124279091632 1.0 0.4416135120700369 4 Q9BXK5 1 |
| Pparalpha pathway 0.5414559338344505 1.1397633353065957 0.2543849126251887 1.0 0.4494133456378333 7 P11310 1 |
| Metapathway biotransformation phase i and ii 0.428934383969805 1.1322370269615512 0.2575347971368176 1.0 0.4536035852893192 20 P78417,Q6UW02,Q8NCH0,P21964,Q7LGA3,P07099 6 |
| Vitamin d receptor pathway 0.5207295089723987 1.1036221418431535 0.2697570822112372 1.0 0.4664731376464122 10 P11413,Q96KA5,Q5VV42 3 |
| Progeriaassociated lipodystrophy 0.5124199057105873 1.032503480982548 0.3018363177923895 1.0 0.5013406645953364 9 O60725 1 |
| Cytosolic dnasensing pathway 0.5071085217019221 1.0293186631702298 0.3033299560693381 1.0 0.5023902397398412 10 Q7Z434 1 |
| Genes related to primary cilium development based on crispr 0.4846136657139681 0.9899823608358966 0.3221827407799509 1.0 0.5256059337104333 12 O95684,Q10713,Q96J42 3 |
| Cholesterol biosynthesis pathway 0.499702240326722 0.9889981798801504 0.3226640321892542 1.0 0.5256059337104333 10 Q16850,P14324,Q15800,P48449 4 |
| Ccl18 signaling pathway 0.4876187754191332 0.9234124505834356 0.3557923057933583 1.0 0.5651959517098852 10 Q86UE4,P00403,P08670,P42224,P07196 5 |
| Influence of laminopathies on wnt signaling 0.4943034888586284 0.9158962734106112 0.3597213015696197 1.0 0.5683401593904831 8 O60725 1 |
| 15q112 copy number variation syndrome 0.4362989323843418 0.9007222138942907 0.3677360346801315 1.0 0.5794327249149099 3 Q06787,Q7L576 2 |
| Copper homeostasis 0.4855271070984155 0.8705047255095706 0.3840246379003507 1.0 0.5954424571699586 8 O75880,O43819 2 |
| Autophagy 0.4664985486788879 0.8410108713195541 0.4003418441500663 1.0 0.6125965751692617 5 P54619,P42345,Q7Z3C6 3 |
| Glycerophospholipid biosynthetic pathway 0.4681677902133573 0.7673473485510696 0.4428750239401022 1.0 0.6584820432861488 7 O00116 1 |
| Vitamin dsensitive calcium signaling in depression 0.467165686571441 0.7510630533806887 0.4526147097084319 1.0 0.6680363943291538 6 P11413 1 |
| Myd88 distinct inputoutput pathway 0.3852721451440947 0.7417014057532372 0.4582682679106389 1.0 0.6716830952269573 2 P61088 1 |
| Interleukin1 induced activation of nfkb 0.3852721451440947 0.7417014057532372 0.4582682679106389 1.0 0.6716830952269573 2 P61088 1 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.4280974942911522 0.7393509485982188 0.4596939193748817 1.0 0.6716830952269573 4 P62942 1 |
| Tgfbeta receptor signaling 0.4280974942911522 0.7393509485982188 0.4596939193748817 1.0 0.6716830952269573 4 P62942 1 |
| Novel intracellular components of rigilike receptor rlr pathway 0.4517533102630877 0.7133851853252487 0.475607437831838 1.0 0.6863344956830731 9 Q7Z434 1 |
| Glial cell differentiation 0.3778014941302115 0.7009704063408435 0.4833214839329784 1.0 0.6889269365168109 2 P09543 1 |
| Angiopoietinlike protein 8 regulatory pathway 0.350032057500384 0.6718318758271785 0.501690733469164 1.0 0.6989300323856431 24 P54619,Q9UPT5,O00767,O75955,Q15382,Q15418,O14654,Q14254,P51812,P46108,P41440,P42345 12 |
| Endothelin pathways 0.4458813962655688 0.6691454156127625 0.5034027216798922 1.0 0.6989300323856431 8 P42892,P00403 2 |
| Fatty acid betaoxidation 0.3591024580577457 0.59452038484363 0.5521641122108452 1.0 0.7434449824917384 19 P11310,O43772,P23786 3 |
| Camkk2 pathway 0.424976527261392 0.592184156923986 0.5537272773011725 1.0 0.7438318033792249 10 P09601,Q9Y3D6,O76024 3 |
| Immune response to tuberculosis 0.3550337958022174 0.5799335112340426 0.5619594560183898 1.0 0.7497079241618336 2 P42224 1 |
| Calcium regulation in cardiac cells 0.3367228041282719 0.573406132938492 0.5663697387422761 1.0 0.7521493341383758 25 P16615,P23634,Q9UBI6,P63096,P62942,Q14012,P54709,P04899,P10644,P63218 10 |
| Neural crest cell migration in cancer 0.3912424350302663 0.5565506718717762 0.577834464474392 1.0 0.7637150862111545 4 Q99523,P63000,Q13177 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.3672597864768726 0.540017092352012 0.5891852449844737 1.0 0.7736373824908742 3 P08195,Q15758 2 |
| Vitamin b12 disorders 0.3658362989323859 0.5330179202100792 0.5940211754448734 1.0 0.7769720130504356 3 P22033,Q99707 2 |
| Spinal cord injury 0.353493912615527 0.5141976290980511 0.6071138252164703 1.0 0.7779062859367081 18 Q9NQC3,P62942,Q08722 3 |
| Ras and bradykinin pathways in covid19 0.3608540925266909 0.5087175746942594 0.6109502017602457 1.0 0.7793959904293726 3 Q99829,P61586 2 |
| G protein signaling pathways 0.3951264236316613 0.4923669108011343 0.6224599866334177 1.0 0.7863380221497575 12 Q9UBI6,P63096,O43823,P04899,P10644,P63218 6 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.397588205119181 0.4561810142883669 0.6482598167996367 1.0 0.7973322219286672 10 Q7Z434 1 |
| Mitochondrial gene expression 0.3689025601505737 0.4521648628154591 0.6511502190629657 1.0 0.7975222220876239 4 Q9P2K5,O00411 2 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3968383489321364 0.4266419723344608 0.669640121694614 1.0 0.8099589023816597 6 Q05086,P54619,Q15382 3 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3941125274682674 0.4178951444554892 0.6760237827556941 1.0 0.8120024213882953 7 Q15118 1 |
| Kallmann syndrome 0.360982556069779 0.4166959489803887 0.6769008178296938 1.0 0.8120024213882953 4 P36507,P62993,Q06124 3 |
| Allograft rejection 0.3746312244266248 0.3582032196624933 0.7201912379523474 1.0 0.8342104151643986 11 Q9BY49,P08670,P42224,P08183 4 |
| Mthfr deficiency 0.3785397914693663 0.3505915909986828 0.7258947660126294 1.0 0.8380131655155701 6 P21964 1 |
| Physiological and pathological hypertrophy of the heart 0.3611111111111063 0.3474036747906884 0.7282880729816823 1.0 0.8391145188701992 5 Q9P2K5,P61586,P63000,Q16539 4 |
| Eicosanoid metabolism via lipooxygenases lox 0.3755375677385149 0.3385661670113302 0.7349365736075897 1.0 0.8451045806966959 6 P09960 1 |
| Ppar signaling pathway 0.3300614722776247 0.3114784040421817 0.7554369579926927 1.0 0.860273671074886 16 P11310,O15254,Q13418,P23786 4 |
| Nuclear receptors metapathway 0.2927734878508371 0.2783240438549216 0.7807636206743571 1.0 0.8777750832460466 41 P11310,P08183,P11413,P09601,P23786,Q15185 6 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.3405975978237463 0.2552873781099577 0.7985011478625095 1.0 0.8884159895658618 13 P43490 1 |
| Gastric cancer network 2 0.3276638317450808 0.1762732937312889 0.8600792420095975 1.0 0.932018955560586 12 Q86UE4 1 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.331120377082628 0.1719059643845161 0.8635114574925564 1.0 0.933850081381763 8 P51812 1 |
| Target of rapamycin tor signaling 0.3304072372500153 0.1694983391164423 0.8654046786534928 1.0 0.933850081381763 8 P62942,P54619,P42345,Q15382 4 |
| Cannabinoid receptor signaling 0.3105413105413085 0.1643763915813856 0.8694348475601916 1.0 0.9352039042944496 5 Q8NCG7,P10644,P28482,Q16539 4 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.2890708437166317 0.1467751515943114 0.8833094983968284 1.0 0.940956129677292 4 P18031,P61201,P06730 3 |
| Nrf2 pathway 0.2951410861543529 0.1463786878238144 0.883622450735984 1.0 0.940956129677292 17 P11413 1 |
| Serotonin htr1 group and fos pathway 0.3146644241421577 0.1160317000561285 0.907627418457011 1.0 0.9546008428605472 9 P63096 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2882258019666769 0.1132659787905289 0.9098196886202536 1.0 0.9546008428605472 17 Q14739,P42167,O94901 3 |
| Regulatory circuits of the stat3 signaling pathway 0.310762651461147 0.1125451175311849 0.9103911983369884 1.0 0.9546008428605472 7 P28482,Q16539,Q13263,P16949,Q96B36,P42345 6 |
| Praderwilli and angelman syndrome 0.2814665833657881 0.0844347230480719 0.9327108008449 1.0 0.9744989191623236 5 P11802,Q05086 2 |
| Hepatitis c and hepatocellular carcinoma 0.2870898716119853 0.0394875318437983 0.9685016939122016 1.0 1.0 9 P04637,P63000,Q16539,Q14247,P31350,P27361,P62993,Q06124 8 |
| Regucalcin in proximal tubule epithelial kidney cells 0.2693266832917701 0.0249749022133604 0.9800749824953948 1.0 1.0 6 P28482,Q8NE86,Q13283,P42574,P42345 5 |
| Amyotrophic lateral sclerosis als 0.2823971974229866 0.0222296846164545 0.9822647385378604 1.0 1.0 12 Q9BUN8 1 |
|
|
